Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer
- 1 July 1994
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 70 (1) , 145-150
- https://doi.org/10.1038/bjc.1994.265
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapyCancer Treatment Reviews, 1993
- 4-hydroxyandrostenedione: A new treatment for postmenopausal patients with breast cancerEuropean Journal Of Cancer, 1992
- The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patientsEuropean Journal Of Cancer, 1992
- Clinical use of aromatase inhibitors in human breast carcinomaThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Aromatase inhibitors and hormone-dependent cancersThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Postmenopausal estrogen synthesis and metabolism: Alterations caused by aromatase inhibitors used for the treatment of breast cancerJournal of Steroid Biochemistry, 1990
- Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedioneCancer Chemotherapy and Pharmacology, 1990
- Mechanisms of Action of Aminoglutethimide as Endocrine Therapy of Breast CancerDrugs, 1988
- 4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCERThe Lancet, 1984
- URINARY 17-HYDROXYCORTICOSTEROIDS MEASURED BY GAS-LIQUID CHROMATOGRAPHYJournal of Endocrinology, 1966